---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-017038"
form_type: "8-K"
ticker: "ENSC"
cik: "0001716947"
company_name: "Ensysce Biosciences, Inc."
filed_at: "2023-05-15T23:59:59+00:00"
generated_at: "2026-06-15T01:18:45.220588+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Ensysce closes $7M public offering of common stock and warrants

## Summary
- Offered 1,800,876 shares (or pre-funded warrants) plus Series A-1/A-2 warrants at $3.887 per unit.
- Gross proceeds ~$7M; net proceeds for clinical development and working capital.
- H.C. Wainwright acted as exclusive placement agent for the offering.
- Amended 210,085 existing warrants from $16.80-$187.20 to $3.637 per share at $0.125 per amended warrant.

## SEC filing metadata
- accession: 0001493152-23-017038
- form_type: 8-K
- ticker: ENSC
- cik: 0001716947
- company_name: Ensysce Biosciences, Inc.
- filed_at: 2023-05-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1716947/000149315223017038/0001493152-23-017038-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1716947/000149315223017038/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-017038
- JSON: https://secwatch.observer/filing/0001493152-23-017038.json
- Plain text: https://secwatch.observer/filing/0001493152-23-017038.txt

## Key facts
- Material Agreements
  Ensysce Biosciences, Inc. entered into Purchase Agreement with certain institutional investors valued at approximately $7.0 million (effective 2023-05-10).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: certain institutional investors
  - Value: approximately $7.0 million
  - Effective: 2023-05-10
  source text: In connection with the offering of the Shares, we entered into a definitive Securities Purchase Agreement (the “ Purchase Agreement ”) with certain institutional investors (the “ Purchasers ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1716947/000149315223017038/0001493152-23-017038-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.